Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in erosive hand osteoarthritis
NCT00185562Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jun 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of adalimumab in erosive hand osteoarthritis (EHOA), sponsored by Stanford University. Primary endpoint: Safety. Started Jun 2005; status: completed.
02
Drugs
03
Conditions
erosive hand osteoarthritis (EHOA)
Beyond the preview
Go deeper on NCT00185562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185562.